IOVS Archives of Disease in Childhood
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2003;44:3771-3777.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0121

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Leeuwen, R.
Right arrow Articles by de Jong, P. T. V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Leeuwen, R.
Right arrow Articles by de Jong, P. T. V. M.

Blood Pressure, Atherosclerosis, and the Incidence of Age-Related Maculopathy: The Rotterdam Study

Redmer van Leeuwen,1 M. Kamran Ikram,1 Johannes R. Vingerling,1,2 Jacqueline C. M. Witteman,1 Albert Hofman,1 and Paulus T. V. M. de Jong1,3,4

1From the Departments of Epidemiology and Biostatistics and 2Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; 3The Netherlands Ophthalmic Research Institute, Royal Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands; and 4Department of Ophthalmology, Academic Medical Center, Amsterdam, The Netherlands.

PURPOSE. To determine whether blood pressure and subclinical atherosclerosis are associated with incident age-related maculopathy (ARM).

METHODS. The study was performed within the Rotterdam Study, a population-based, prospective cohort study in Rotterdam, The Netherlands. A total of 4822 subjects who at baseline were aged 55 years more, were free of ARM, and participated in at least one of two follow-up examinations after a mean of 2 and 6.5 years, were included in the study. At baseline, blood pressure and the presence of atherosclerosis were determined. ARM was assessed according to the International Classification and Grading System and defined as large, soft drusen with pigmentary changes; indistinct drusen; or atrophic or neovascular age-related macular degeneration.

RESULTS. After a mean follow-up of 5.2 years, incident ARM was diagnosed in 417 subjects. Increased systolic blood pressure or pulse pressure was associated with a higher risk of ARM. Adjusted for age, gender, smoking, total and high-density lipoprotein cholesterol, body mass index, and diabetes mellitus, odds ratios (OR) per 10-mm Hg increase were 1.08 (95% confidence interval [CI]: 1.03–1.14) and 1.11 (95% CI: 1.04–1.18), respectively. Moreover, different measures of atherosclerosis were associated with the risk of ARM. An increase in carotid wall thickness (OR per 1 SD, 1.15; 95% CI: 1.03–1.28) increased the risk of ARM. The lowest compared with the highest tertile of ankle–arm index had an OR of 1.32 (95% CI: 1.00–1.75). A weak association was found between aortic calcifications and the risk of ARM.

CONCLUSIONS. Elevated systolic blood or pulse pressure or the presence of atherosclerosis may increase the risk of development of ARM.





This article has been cited by other articles:


Home page
IOVSHome page
K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, S. Ohno, Y. Oike, and S. Ishida
Inhibition of Choroidal Neovascularization with an Anti-Inflammatory Carotenoid Astaxanthin
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1679 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, K. Umezawa, S. Ohno, Y. Oike, and S. Ishida
Macular Pigment Lutein Is Antiinflammatory in Preventing Choroidal Neovascularization
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2555 - 2562.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
S. S. Boekhoorn, J. R. Vingerling, J. C. M. Witteman, A. Hofman, and P. T. V. M. de Jong
C-reactive Protein Level and Risk of Aging Macula Disorder: The Rotterdam Study
Arch Ophthalmol, October 1, 2007; 125(10): 1396 - 1401.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Koto, N. Nagai, H. Mochimaru, T. Kurihara, K. Izumi-Nagai, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, et al.
Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4328 - 4334.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
J. S. L. Tan, P. Mitchell, A. Kifley, V. Flood, W. Smith, and J. J. Wang
Smoking and the Long-term Incidence of Age-Related Macular Degeneration: The Blue Mountains Eye Study
Arch Ophthalmol, August 1, 2007; 125(8): 1089 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
S. Cugati, R. G. Cumming, W. Smith, G. Burlutsky, P. Mitchell, and J. J. Wang
Visual Impairment, Age-Related Macular Degeneration, Cataract, and Long-term Mortality: The Blue Mountains Eye Study
Arch Ophthalmol, July 1, 2007; 125(7): 917 - 924.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Izumi-Nagai, N. Nagai, Y. Ozawa, M. Mihara, Y. Ohsugi, T. Kurihara, T. Koto, S. Satofuka, M. Inoue, K. Tsubota, et al.
Interleukin-6 Receptor-Mediated Activation of Signal Transducer and Activator of Transcription-3 (STAT3) Promotes Choroidal Neovascularization
Am. J. Pathol., June 1, 2007; 170(6): 2149 - 2158.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Nagai, Y. Oike, K. Izumi-Nagai, T. Koto, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, et al.
Suppression of Choroidal Neovascularization by Inhibiting Angiotensin-Converting Enzyme: Minimal Role of Bradykinin
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2321 - 2326.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
R. Klein, B. E. K. Klein, M. D. Knudtson, M. F. Cotch, T. Y. Wong, K. Liu, G. L. Burke, M. F. Saad, D. R. Jacobs Jr, and A. R. Sharrett
Subclinical Atherosclerotic Cardiovascular Disease and Early Age-Related Macular Degeneration in a Multiracial Cohort: The Multiethnic Study of Atherosclerosis
Arch Ophthalmol, April 1, 2007; 125(4): 534 - 543.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
N. Cheung, D. Liao, F M Amirul Islam, R. Klein, J. Jin Wang, and T. Yin Wong
Is early age-related macular degeneration related to carotid artery stiffness? The Atherosclerosis Risk in Communities Study
Br. J. Ophthalmol., April 1, 2007; 91(4): 430 - 433.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
I. C. Munch, B. Sander, L. Kessel, J. L. Hougaard, N. C. B. B. Taarnhoj, T. I. A. Sorensen, K. O. Kyvik, and M. Larsen
Heredity of Small Hard Drusen in Twins Aged 20-46 Years
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 833 - 838.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Tummala, M. Ali, P. Getty, P. M. Hocking, D. W. Burt, C. F. Inglehearn, and D. H. Lester
Mutation in the Guanine Nucleotide-Binding Protein {beta}-3 Causes Retinal Degeneration and Embryonic Mortality in Chickens
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4714 - 4718.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Nagai, Y. Oike, K. Izumi-Nagai, T. Urano, Y. Kubota, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, T. Suda, et al.
Angiotensin II Type 1 Receptor-Mediated Inflammation Is Required for Choroidal Neovascularization
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2252 - 2259.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
L Xu, Y Li, Y Zheng, and J B Jonas
Associated factors for age related maculopathy in the adult population in China: the Beijing eye study
Br. J. Ophthalmol., September 1, 2006; 90(9): 1087 - 1090.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
T. Y. Wong, R. Klein, C. Sun, P. Mitchell, D. J. Couper, H. Lai, L. D. Hubbard, A. R. Sharrett, and for the Atherosclerosis Risk in Communities Study
Age-Related Macular Degeneration and Risk for Stroke
Ann Intern Med, July 18, 2006; 145(2): 98 - 106.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
B. Chua, V. Flood, E. Rochtchina, J. J. Wang, W. Smith, and P. Mitchell
Dietary Fatty Acids and the 5-Year Incidence of Age-Related Maculopathy
Arch Ophthalmol, July 1, 2006; 124(7): 981 - 986.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
M A Mainster
Violet and blue light blocking intraocular lenses: photoprotection versus photoreception
Br. J. Ophthalmol., June 1, 2006; 90(6): 784 - 792.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. G. Arroyo
A 76-year-old man with macular degeneration.
JAMA, May 24, 2006; 295(20): 2394 - 2406.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T I Metelitsina, J E Grunwald, J C DuPont, and G-S Ying
Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration.
Br. J. Ophthalmol., March 1, 2006; 90(3): 342 - 346.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
G. McGwin Jr, K. Modjarrad, T. A. Hall, A. Xie, and C. Owsley
3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Presence of Age-Related Macular Degeneration in the Cardiovascular Health Study
Arch Ophthalmol, January 1, 2006; 124(1): 33 - 37.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. van Leeuwen, S. Boekhoorn, J. R. Vingerling, J. C. M. Witteman, C. C. W. Klaver, A. Hofman, and P. T. V. M. de Jong
Dietary Intake of Antioxidants and Risk of Age-Related Macular Degeneration
JAMA, December 28, 2005; 294(24): 3101 - 3107.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
J L Duncan
Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration
Br. J. Ophthalmol., December 1, 2005; 89(12): 1549 - 1551.
[Full Text] [PDF]


Home page
Arch OphthalmolHome page
B. Dasch, A. Fuhs, T. Behrens, A. Meister, J. Wellmann, M. Fobker, D. Pauleikhoff, and H.-W. Hense
Inflammatory Markers in Age-Related Maculopathy: Cross-sectional Analysis From the Muenster Aging and Retina Study
Arch Ophthalmol, November 1, 2005; 123(11): 1501 - 1506.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Sivaprasad, N. V. Chong, and T. A. Bailey
Serum Elastin-Derived Peptides in Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3046 - 3051.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
H A Moeini, H Masoudpour, and H Ghanbari
A study of the relation between body mass index and the incidence of age related macular degeneration
Br. J. Ophthalmol., August 1, 2005; 89(8): 964 - 966.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Fernandez-Robredo, D. Moya, J. A. Rodriguez, and A. Garcia-Layana
Vitamins C and E Reduce Retinal Oxidative Stress and Nitric Oxide Metabolites and Prevent Ultrastructural Alterations in Porcine Hypercholesterolemia
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1140 - 1146.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
M. A. Mainster
Intraocular Lenses Should Block UV Radiation and Violet but Not Blue Light
Arch Ophthalmol, April 1, 2005; 123(4): 550 - 555.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
E Friedman
Update of the vascular model of AMD
Br. J. Ophthalmol., February 1, 2004; 88(2): 161 - 163.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology